Bioavailability of oral vitamin e formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 5, 2009, Pages 515-522

  Jacquemin, E ^a   Hermeziu, B ^a   Kibleur, Y ^b   Friteau, I ^a   Mathieu, D ^c   Le Coz, F ^d   Moyse, D ^e   Gerardin M ^f   Jacqz Aigrain, E ^f   Munck, A ^f  

^a BICÊTRE HOSPITAL   (France)

^b Orphan Europe   (France)

^c CIT   (France)

^d Biotrial   (France)

^e DM Consultant ^*  (New Zealand)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Biliary atresia; Children; Cholestasis; Cystic fibrosis; Pharmacokinetics; Tocofersolan; TPGS; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; BILE ACID; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; TOCOFERSOLAN;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BILE DUCT ATRESIA; BIOEQUIVALENCE; CHILD; CHOLESTASIS; CHRONIC CHOLECYSTITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG SAFETY; FEMALE; HUMAN; INFANT; LOADING DRUG DOSE; MALE; MAXIMUM PLASMA CONCENTRATION; MISCIBILITY; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHILD; CHILD, PRESCHOOL; CHOLESTASIS; CHRONIC DISEASE; CROSS-OVER STUDIES; CYSTIC FIBROSIS; HUMANS; INFANT; MIDDLE AGED; VITAMIN E;

EID: 70049090739     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01027.x     Document Type: Article

References (12)

1. Schneider C (2005) Chemistry and biology of vitamin E. Molecular Nutrition & Food Research, 49, 7 30.
2. Kayden HJ, Traber MG (1993) Absorption, lipoprotein transport and regulation of plasma concentrations of vitamin E in human. Journal of Lipid Research, 34, 343 358.
3. Steinijans VW, Hauschke D (1993) International harmonisation of regulatory bioequivalence requirements. Clinical Research and Regulatory Affairs, 10, 203 220.
4. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board (2000) Institute of medicine, dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington : National Academies Press.
5. Sokol RJ, Heubi JE, Butler-Simon N, McClung HJ, Lilly JR, Silverman A (1987) Treatment of vitamin E deficiency during chronic childhood cholestasis with oral d-α-tocopheryl polyethylene glycol-1000 succinate. Gastroenterology 93, 975 985. (Pubitemid 18000639)
6. Sokol RJ, Butler-Simon NA, Bettis D, Smith DJ, Silverman A (1987) Tocopherol polyethylene glycol 1000 succinate therapy for vitamin E deficiency during chronic childhood cholestasis: neurologic outcome. Journal of Pediatrics, 111, 830 836. (Pubitemid 18019154)
7. Lehmann J, Martin HL (1987) Improved direct determination of alpha- and gamma-tocopherols in plasma and platelets by liquid chromatography, with fluorescence detection. Clinical Chemistry, 28, 1784 1787.
8. Reiz JL, Donnelly GA, Michalko K (2008) Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults. Clinical Therapeutics, 30, 59 69.
9. Schiavi P, Jochemsen R, Guez D (2000) Pharmacokinetics of sustained and immediate release formulations of indapamide after single and repeated oral administration in healthy volunteers. Fundamental and Clinical Pharmacology, 14, 139 146.
10. Melhorn DK (1973) Vitamin E: who needs it? II. Diseases associated with vitamin E deficiency Ohio State Medical Journal, 69, 830 833.
11. Papas K, Kalbfleisch J, Mohon R (2007) Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. Digestive Diseases and Sciences, 52, 347 352.
12. Sokol RJ, Butler-Simon N, Conner C et al. (1993) Multicenter trial of d-alpha-Tocopherol polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. Gastroenterology, 104, 1727 1735.